Zhejiang Jingxin Pharmaceutical Co., Ltd.

SZSE:002020 Stock Report

Market Cap: CN¥14.7b

Zhejiang Jingxin Pharmaceutical Management

Management criteria checks 3/4

Zhejiang Jingxin Pharmaceutical's CEO is Lv Gang, appointed in Jul 2023, has a tenure of 2.5 years. directly owns 21.97% of the company’s shares, worth CN¥3.22B. The average tenure of the management team and the board of directors is 2.5 years and 3.6 years respectively.

Key information

Lv Gang

Chief executive officer

CN¥1.5m

Total compensation

CEO salary percentagen/a
CEO tenure2.5yrs
CEO ownership22.0%
Management average tenure2.5yrs
Board average tenure3.6yrs

Recent management updates

Recent updates

Is There An Opportunity With Zhejiang Jingxin Pharmaceutical Co., Ltd.'s (SZSE:002020) 44% Undervaluation?

Mar 30
Is There An Opportunity With Zhejiang Jingxin Pharmaceutical Co., Ltd.'s (SZSE:002020) 44% Undervaluation?

Benign Growth For Zhejiang Jingxin Pharmaceutical Co., Ltd. (SZSE:002020) Underpins Its Share Price

Jan 24
Benign Growth For Zhejiang Jingxin Pharmaceutical Co., Ltd. (SZSE:002020) Underpins Its Share Price

Zhejiang Jingxin Pharmaceutical (SZSE:002020) Seems To Use Debt Quite Sensibly

Jan 03
Zhejiang Jingxin Pharmaceutical (SZSE:002020) Seems To Use Debt Quite Sensibly

We Think Zhejiang Jingxin Pharmaceutical (SZSE:002020) Can Stay On Top Of Its Debt

Oct 04
We Think Zhejiang Jingxin Pharmaceutical (SZSE:002020) Can Stay On Top Of Its Debt

Zhejiang Jingxin Pharmaceutical Co., Ltd.'s (SZSE:002020) Low P/E No Reason For Excitement

Sep 12
Zhejiang Jingxin Pharmaceutical Co., Ltd.'s (SZSE:002020) Low P/E No Reason For Excitement

Zhejiang Jingxin Pharmaceutical (SZSE:002020) Has Announced A Dividend Of CN¥0.30

May 21
Zhejiang Jingxin Pharmaceutical (SZSE:002020) Has Announced A Dividend Of CN¥0.30

Zhejiang Jingxin Pharmaceutical's (SZSE:002020) Problems Go Beyond Weak Profit

Apr 08
Zhejiang Jingxin Pharmaceutical's (SZSE:002020) Problems Go Beyond Weak Profit

We Think Zhejiang Jingxin Pharmaceutical (SZSE:002020) Can Stay On Top Of Its Debt

Mar 29
We Think Zhejiang Jingxin Pharmaceutical (SZSE:002020) Can Stay On Top Of Its Debt

CEO

Lv Gang (63 yo)

2.5yrs
Tenure
CN¥1,483,600
Compensation

Mr. Lv Gang serves as Chairman of the Board at Zhejiang Jingxin Pharmaceutical Co. Ltd. (a/k/a Zhejiang Jingxin Pharmaceutical Co., Ltd. (formerly known as Zhejiang Jingxin Pharmaceutical Factory)) and ser...

Leadership Team

NamePositionTenureCompensationOwnership
Lv Gang
President & Chairman of the Board2.5yrsCN¥1.48m21.97%
CN¥ 3.2b
Chen Meili
VP, CFO & Director10yrsCN¥807.70k0.046%
CN¥ 6.8m
Jin Zhiping
VP & Director2.5yrsCN¥969.70kno data
Yunfei Hong
Secretary of the Board & Non-Independent Directorno dataCN¥885.70kno data
Zhi Bin Zhu
Vice Presidentno dataCN¥849.10kno data
Sheng Liu
Vice Presidentno dataCN¥853.90kno data
Ye Zhen Zhou
Accounting Supervisorno datano datano data
Jun Min Wang
Vice Presidentno datano datano data
2.5yrs
Average Tenure
52yo
Average Age

Experienced Management: 002020's management team is considered experienced (2.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Lv Gang
President & Chairman of the Board12.3yrsCN¥1.48m21.97%
CN¥ 3.2b
Chen Meili
VP, CFO & Director12.3yrsCN¥807.70k0.046%
CN¥ 6.8m
Jin Zhiping
VP & Director12.3yrsCN¥969.70kno data
Yunfei Hong
Secretary of the Board & Non-Independent Director6.3yrsCN¥885.70kno data
Wang Nengneng
Vice Chairman12.3yrsCN¥864.80k0.44%
CN¥ 64.4m
Tianqing Hu
Chairman of the Supervisory Boardno dataCN¥310.80kno data
Pan Xu
Independent Director3.3yrsCN¥80.00kno data
Hu Wan
Non-Independent Director3.6yrsCN¥603.80kno data
Zhang Daliang
Independent Director3.3yrsCN¥80.00kno data
Lei Ying
Independent Director3.3yrsCN¥80.00kno data
Tao Huang
Independent Directorless than a yearno datano data
Jiaqi Lv
Non-Independent Directorless than a yearno datano data
3.6yrs
Average Tenure
53.5yo
Average Age

Experienced Board: 002020's board of directors are considered experienced (3.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/23 13:33
End of Day Share Price 2026/01/23 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Zhejiang Jingxin Pharmaceutical Co., Ltd. is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shitong HanCitic Securities Co., Ltd.
Mingrui WangEverbright Securities Co. Ltd.
Weina JiangGuosen Securities Co., Ltd.